Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 million people i...

French pharmaceutical company Sanofi has entered exclusive talks to sell a 50% stake in its consumer health business Opella to U.S. private...

The announcement comes a day after ET reported that the company had ceased production of its ShanIPV vaccines in India, which may lead to a...

Sanofi is reviewing options for the potential split, but said the most likely course would be a “capital markets transaction” to form a sep...

The company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovati...

The leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India i...

The drugmaker is offering voluntary retirement scheme (VRS) to all its employees at two sites near Hyderabad, a spokesperson for Sanofi's I...

"An approval has been granted after the Valneva Covid-19 vaccine was found to meet the required safety, quality and effectiveness standards...

COVAX aims to deliver 2 billion vaccine doses around the world by the end of 2021, and more than 180 nations have joined the plan. The Unit...

Many of the jobs lost will be from GSK's Research Triangle Park site as drug research is consolidated in Philadelphia and in Stevenage, nea...

Novo is betting big on Tresiba in the emerging markets after it failed to get an approval for the drug from the US Food and Drug Administra...

French drug-maker Sanofi has entered into an agreement to acquire the animal health division of Indian firm Dosch Pharmaceuticals for an un...

It was also believed to been in the fray to buy Actis' 63% stake in Paras Pharmaceuticals, that was eventually acquired by Reckitt Benckise...

Biotech firm Genzyme Corp. says its board of directors is rejecting Sanofi-Aventis SA's $69 a share offer and recommending Genzyme sharehol...

Piramal Heathcare Ltd said on Wednesday its founder has no proposal to sell any stake in the company, sending the shares down 8 percent.

Ranbaxy's French unit has been raided by European antitrust officials as part of a probe on cozy drug settlements which allegedly delay the...

Bristol-Myers Squibb, which fired its chief executive officer this week, may be targeted for takeover by Schering-Plough or French drugmake...